Gallbladder Cancer
Showing 9951 - 9975 of >10,000
Social Determinants of Cardiotoxicity in Prostate Cancer
Recruiting
- Prostate Cancer
- +3 more
- Social Determinants of Health
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 19, 2023
Unresectable Hepatocellular Carcinoma Trial in Worldwide (TheraSphere)
Completed
- Unresectable Hepatocellular Carcinoma
- TheraSphere
-
Phoenix, Arizona
- +93 more
Jan 19, 2023
Social Determinants of Cardiotoxicity in Breast Cancer
Recruiting
- Breast Cancer
- +3 more
- Social Determinants of Health
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 19, 2023
s for Colorectal Cancer of Quantitative FIT in Symptomatic
Recruiting
- Colorectal Cancer
-
Örebro, SwedenSkebäcks VC
Dec 1, 2021
Head Neck Cancer Trial in Oklahoma City (Ecologic Momentary Assessment (EMA))
Recruiting
- Head and Neck Cancer
- Ecologic Momentary Assessment (EMA)
-
Oklahoma City, OklahomaStephenson Cancer Center
Apr 28, 2023
Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)
Recruiting
- Carcinoma, Renal Cell
- Carcinoma, Non-Small-Cell Lung
- Live Bacterial Product - Akkermansia muciniphila
-
Mons, Belgium
- +3 more
May 9, 2023
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Cancer Trial in Næstved (Calcium electroporation)
Recruiting
- Cancer
- Calcium electroporation
-
Næstved, DenmarkDept. of Clinical oncology and Palliative Care
Feb 15, 2022
Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)
Active, not recruiting
- Colorectal Cancer Metastatic
- mCRC
- Aldoxorubicin Hydrochloride
- +19 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Recurrent or Metastatic Cervical Cancer Trial in Shanghai (SHR-1210, SHR-1020, Physician's choice chemo)
Active, not recruiting
- Recurrent or Metastatic Cervical Cancer
- SHR-1210
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 14, 2022
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed
Recruiting
- Prostate Cancer
- +4 more
- Darolutamide
- metastasis-directed treatment
-
Aalst, Belgium
- +6 more
Jan 25, 2023
NSCLC Stage III Trial in Hefei (Envafolimab)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
-
Hefei, Anhui, ChinaAnhui Provincial Cancer Hospital
Jun 8, 2022
Skin Necrosis, Complication Trial in A Coruña (ICG angiography)
Recruiting
- Skin Necrosis
- Complication
- ICG angiography
-
A Coruña, SpainHospital Abente y Lago
Jun 17, 2023
Mental Disorders, Psychosocial Distress and Care Needs of
Recruiting
- Neoplasm Malignant
-
Leipzig, Saxony, GermanyDepartment of Medical Psychology and Medical Sociology, Universi
May 17, 2022
Pleural Effusion Trial in United Kingdom, United States (Vacuum-Based IPC, Gravity-Based IPC)
Recruiting
- Pleural Effusion
- Vacuum-Based IPC
- Gravity-Based IPC
-
Arlington Heights, Illinois
- +5 more
Dec 6, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With
Active, not recruiting
- Previously Treated Myelodysplastic Syndrome
- +7 more
- Decitabine
- Ipilimumab
-
Duarte, California
- +10 more
Jul 2, 2022
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)
Recruiting
- Diffuse Large B-cell Lymphoma
- +7 more
- GEN3009
- Epcoritamab
-
Tucson, Arizona
- +31 more
Jul 1, 2022
Breast CANcer Risk Assessment in Younger Women: BCAN-RAY
Not yet recruiting
- Breast Cancer Female
- Mammogram
- (no location specified)
Jul 5, 2022
Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,
Recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- HA Chemotherapy
-
Durham, North CarolinaDuke University Health System
Nov 22, 2022
Lung Cancer, Smoking Cessation Trial in Aurora (Patient decision aid)
Active, not recruiting
- Lung Cancer
- Smoking Cessation
- Patient decision aid
-
Aurora, ColoradoUniversity of Colorado Hospital
Jun 10, 2022
Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)
Recruiting
- Microsatellite Stable Metastatic Colorectal Cancer
- Regorafenib
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 19, 2023
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
HLX07, nsqNSCLC, High EGFR Expression Trial in Shanghai (HLX07+carboplatin+pemetrexed, HLX07+docetaxel, HLX07)
Not yet recruiting
- HLX07, nsqNSCLC, High EGFR Expression
- HLX07+carboplatin+pemetrexed
- +2 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 5, 2022
Therapeutic Care in Metastatic Breast Cancer From 2008
Recruiting
- Metastatic Breast Cancer
-
Angers, France
- +19 more
Jun 30, 2022